当前位置: X-MOL 学术Allergy › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Tolerance mechanisms of AIT
Allergy ( IF 12.4 ) Pub Date : 2020-05-01 , DOI: 10.1111/all.14126
Willem van de Veen 1, 2 , Mübeccel Akdis 1
Affiliation  

Allergen immunotherapy (AIT) is the only curative treatment for allergic diseases. It induces immune tolerance together with the reduction of the symptoms of asthma and allergic rhinitis patients. The common routes for the application of AIT for respiratory allergens are subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). SCIT improves the symptoms of asthma and rhinitis and increase the quality of life.

中文翻译:

AIT的耐受机制

过敏原免疫疗法(AIT)是过敏性疾病的唯一治愈性治疗方法。它诱导免疫耐受,同时减轻哮喘和过敏性鼻炎患者的症状。AIT应用于呼吸道过敏原的常见途径是皮下免疫疗法(SCIT)和舌下免疫疗法(SLIT)。SCIT 可改善哮喘和鼻炎的症状并提高生活质量。
更新日期:2020-05-01
down
wechat
bug